Termination for Safety. Upon reasonable notice to Residents and consultation with public health authorities, University Housing may terminate Residents’ Residence Hall contracts to reduce health risks. Termination of contracts may be necessary to further reduce residential density in the Residence Halls, to expand emergency housing capacity, due to inability to find alternative housing for Residents who need relocation, to close one or all the Residence Halls, or to take other actions in the interest of public health and safety. If, at any time, the University closes the Residence Halls and requires all Residents to leave campus for the remainder of the academic year, Residents will not be charged for the remaining, canceled portion of the Residence Hall contract period.
Termination for Safety. Subject to Section 11.6, Fujisawa may terminate this Agreement in whole or in part (i.e., with respect to a particular Licensed Product and/or indication) at any time upon thirty (30) days prior written notice if: Fujisawa determines that there are safety concerns regarding the Licensed Products such that no Licensed Product could reasonably be developed that would meet Fujisawa's standards for product safety, so long as such determination is made in good faith and that Fujisawa applies the same standards to evaluate the safety of Licensed Products as it typically and customarily would apply for the safety evaluation of other products, including products derived from its own research and development efforts, at similar stages of development. In the event Fujisawa terminates under this Section 11.4(a), it would not owe any milestone payment that became due during the thirty (30) day notice period, or any other monies hereunder with respect to the terminated Licensed Product and/or indication, except for Milestone (2) under Section 5.3(b) in accordance with the terms thereof, where such termination occurred after the dosing of the last patient in the Phase I Trial.
Termination for Safety. 16.2.6.1. SGEN may terminate this Agreement with respect to a Collaboration Product (other than a CoDev Product) immediately upon written notice to PIRS, that such Collaboration Product demonstrates a Safety Issue in humans.
Termination for Safety. Upon reasonable notice to Residents, University Housing may terminate Residents’ Graduate Village contracts to reduce the health risks associated with COVID-19 or other health risks. Termination of contracts may be necessary to further reduce residential density in Graduate Village, to expand emergency housing capacity, due to inability to find alternative housing for Residents who need relocation, to close Graduate Village in part or entirely, or to take other actions in the interest of public health and safety. If, at any time, the University closes Graduate Village pursuant to this paragraph and requires all Residents to leave campus for the remainder of the academic year, Residents will not be charged for the remaining, canceled portion of the Graduate Village contract period.
Termination for Safety. 12.2.5.(a) Servier may terminate this Agreement with respect to (a) the Lead Product or (b) any Collaboration Product, CoDev Collaboration Product or Servier WW Collaboration Product, immediately upon written notice to Pieris, that such Product reasonably demonstrates a safety issue in humans.
Termination for Safety. Notwithstanding anything to the contrary herein, following discovery of a Material Safety Issue, either Party may, upon written notice to the other Party, halt its ongoing Co-Exploited Product Development and Commercialization activities, investigate the Material Safety Issue, and determine a course of action. Following such investigation, such Party may elect to terminate the Co-Exploitation, and if such Party makes such election, then it shall provide written notice to the other Party of such termination and such termination shall take effect immediately. Within [***] days of discovery of a Material Safety Issue, the discovering Party must either elect to terminate the Co-Exploitation, or restart its Co-Exploitation, Development and Commercialization activities and thereafter conduct such activities in accordance with the Co-Exploitation Terms.
Termination for Safety. Takeda may terminate this Agreement in its entirety or with respect to a particular Product upon [***] ([***]) [***] prior written notice to ITI (a) if senior executives responsible for Takeda’s Pharmacovigilance and Clinical Science functions determine in good faith that the risk/benefit profile of such Product(s) is such that the Product(s) cannot continue to be Developed or administered to subjects/patients safely (and not for commercial reasons), or (b) upon the occurrence of serious adverse events related to the use of such Product(s) that cause Takeda to reasonably conclude that the continued use of such Product(s) by subjects/patients will result in subjects/patients being exposed to a product whose risks outweigh its benefits. Following notice of termination under this Section 13.5, the Parties shall cooperate to wind down all Development and Commercialization activities with respect to the terminated Product(s).
Termination for Safety. Xxxxxxx may terminate this Agreement in the event the Licensed Component or Licensed Product Developed hereunder poses a serious safety issue.
Termination for Safety. Upon reasonable notice to Tenants and consultation with public health authorities, University Housing may terminate Tenants’’ Veteran House Agreements to reduce health risks. Termination of Agreements may be necessary to further reduce density in University Housing, to expand emergency housing capacity, due to inability to find alternative housing for Tenants who need relocation, to close one or all the University Housing facilities, or to take other actions in the interest of public health and safety. If, at any time, the University closes Graduate Village and requires all Tenants to leave campus for the remainder of the academic year, Tenants will not be charged for the remaining, canceled portion of the Veteran House Agreement period.
Termination for Safety. EOS shall have the right to terminate this Agreement with at least thirty (30) days written notice at any time (a) if senior executives responsible for EOS’s Pharmacoviligence and Clinical Science functions determine in good faith and in consideration of Commercially Reasonable Efforts that the risk/benefit profile of the Product is such that the Product cannot continue to be Developed or administered to patients safely (and not for commercial reasons), or (b) upon the occurrence of serious adverse events related to the use of Product that cause EOS to reasonably conclude that the continued use of Product by patients will result in patients being exposed to a product in which the risks outweigh the benefits. Upon any such termination, the Parties shall reasonably cooperate with each other in the wind-down and/or, if applicable, transition of all the activities from EOS to Advenchen, or such Third Party designated by Advenchen, and the provisions of Section 14.7(a) and (b) shall apply.
